Enzymatica enters the MENA region

Enzymatica has signed a long-term exclusive distribution agreement with MedonyX, a healthcare company backed by MMDS, for the registration, marketing, sale and distribution of ColdZyme® in Jordan and Iraq. The agreement marks Enzymatica's first step into the MENA region and supports the company's continued international expansion strategy.

Launch is expected in the first quarter of 2027.

Read the press release here